Suzhou Highfine Biotech Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Suzhou Highfine Biotech has a total shareholder equity of CN¥2.2B and total debt of CN¥340.0K, which brings its debt-to-equity ratio to 0.02%. Its total assets and total liabilities are CN¥2.3B and CN¥94.2M respectively. Suzhou Highfine Biotech's EBIT is CN¥85.6M making its interest coverage ratio -4. It has cash and short-term investments of CN¥1.7B.
Anahtar bilgiler
0.02%
Borç/özkaynak oranı
CN¥340.02k
Borç
| Faiz karşılama oranı | -4x |
| Nakit | CN¥1.75b |
| Eşitlik | CN¥2.24b |
| Toplam yükümlülükler | CN¥94.16m |
| Toplam varlıklar | CN¥2.34b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 301393's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥84.9M).
Uzun Vadeli Yükümlülükler: 301393's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥9.3M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 301393 has more cash than its total debt.
Borcun Azaltılması: 301393's debt to equity ratio has increased from 0% to 0.02% over the past 5 years.
Borç Kapsamı: 301393's debt is well covered by operating cash flow (44720.9%).
Faiz Kapsamı: 301393 earns more interest than it pays, so coverage of interest payments is not a concern.